Cancer Letters
Volume 227, Issue 1 , Pages 83-93 , 8 September 2005

Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo

  • Shiro Miyata

      Affiliations

    • Second Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Shunro Uchinokura

      Affiliations

    • Second Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Tsuyoshi Fukushima

      Affiliations

    • Second Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Ryouichi Hamasuna

      Affiliations

    • Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Hiroshi Itoh

      Affiliations

    • Second Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Yutaka Akiyama

      Affiliations

    • Second Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Shinichi Nakano

      Affiliations

    • Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Shinichiro Wakisaka

      Affiliations

    • Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • ,
  • Hiroaki Kataoka

      Affiliations

    • Second Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 985 85 2809; fax: +81 0985 85 6003.

Received 10 November 2004 ,Revised 14 December 2004 ,Accepted 7 January 2005.

References 

  1. Moriyama T, Kataoka H, Tsubouchi H, Koono M. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro, FEBS Lett. 1995;372:78–82
  2. Moriyama T, Kataoka H, Seguchi K, Tsubouchi H, Koono M. Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells. Int J Cancer. 1996;66:678–685
  3. Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Way D, et al. Scatter factor expression and regulation in human glial tumors. Int J Cancer. 1996;67:248–255
  4. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, et al. Woude. Met and hepatocyte growth factor/scatter factor expression in human gliomas, Cancer Res. 1997;57:5391–5398
  5. Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, et al. Scatter factor/hepatecyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest. 1997;76:565–577
  6. Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, et al. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/Ribozyme targeting of scatter factor/hepatecyte growth factor and c-met expression. J Natl Cancer Inst. 1999;91:1548–1556
  7. Kataoka H, Miyata S, Uchinokura S, Itoh H. Roles of hepatocyte growh factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metast Rev. 2003;22:223–236
  8. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem. 1993;268:10024–10028
  9. Lee SL, Dickson RB, Lin CY. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease, J Biol Chem. 2000;275:36720–36725
  10. Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, et al. Hepatocyte growth factor activator inhibitor, a novel Kunitz type serine protease inhibitor, J Biol Chem. 1997;272:6370–6376
  11. Kawaguchi T, Qin L, Shimomura T, Kondo J, Matsumoto K, Denda K, et al. Purification and cloning of Hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inihibitor, J Biol Chem. 1997;272:27558–27564
  12. Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, Kitamura N, et al. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem. 2000;275:40453–40462
  13. Lin CY, Anders J, Johnson M, Dickson RB. Purification characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem. 1999;274:18237–18242
  14. Oberst MD, Williams CA, Dickson RB, Johnson MD, Lin CY. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor, J Biol Chem. 2003;278:26773–26779
  15. Hamasuna R, Kataoka H, Y J. Meng. H. Itoh, T. Moriyama, S. Wakisaka, M. Koono, Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells, Int J Cancer. 2001;93:339–345
  16. Gondi CS, Lakka SS, Yanamandra N, Siddique K, Dinh DH, Olivero WC. M Gujrati, J.S. Rao, Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis, Oncogene. 2003;22:5967–5975
  17. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery. 1996;39:235–252
  18. Kataoka H, Itoh H, Koono M. Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration. Pathol Int. 2000;52:89–102
  19. Devoogdt N, Ghassabeh GH, Zhang J, Brys L, Baetselier PD, Revets H. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci USA. 2003;100:5778–5782
  20. Meng JY, Kataoka H, Itoh H, Koono M. Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int J Cancer. 2001;92:31–39
  21. Ko SY, Lin SC, Chang KW, Wong YK, Liu CJ, Chi CW, et al. Increased expression of amylid precursor protein in oral squamous cell carcinoma. Int J Cancer. 2004;111:727–732
  22. von Koch CS, Zheng H, Chen H, Trumbauer M, Thinakaran G, van der Ploeg LHT, et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurol. Aging. 1997;18:661–669
  23. Mitchell KJ, Pinson KI, Kelly OG, Brennan J, Zupicich J, Scherz P, et al. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet. 2001;28:241–249
  24. Oberst MD, Johnson MD, Dickson RB, Lin C-Y, Singh B, Stewart M, et al. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: Correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res. 2002;8:1101–1107
  25. Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin C-Y, Dickson RB, et al. Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer, Cancer Res. 2003;63:1101–1105
  26. Parr C, Watkins G, Mansel RE, Jiang WG. The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res. 2004;10:202–211
  27. Nagaike K, Kohama K, Uchiyama S, Tanaka H, Chijiiwa K, Itoh H, et al. Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front. Cancer Sci. 2004;95:728–735
  28. Kataoka H, Uchino H, Denda K, Kitamura N, Itoh H, Tsubouchi H, et al. Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa. Cancer Lett. 1998;128:219–227
  29. Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res. 2000;60:6148–6159

PII: S0304-3835(05)00041-8

doi: 10.1016/j.canlet.2005.01.010

Cancer Letters
Volume 227, Issue 1 , Pages 83-93 , 8 September 2005

Article Tools

* Image Usage & Resolution